Relaxo Footwears Limited
Relaxo Footwears Limited (RELAXO.NS) Stock Competitors & Peer Comparison
See (RELAXO.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Footwear & Accessories Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RELAXO.NS | ₹303.00 | +2.92% | 74.4B | 44.32 | ₹6.74 | +1.00% |
| METROBRAND.NS | ₹1,065.00 | -0.33% | 292.7B | 71.27 | ₹15.07 | +0.51% |
| METROBRAND.BO | ₹1,072.45 | +0.39% | 291.9B | 71.12 | ₹15.06 | +0.51% |
| SAFARIND.BO | ₹1,915.30 | -0.29% | 91.1B | 1394.97 | ₹1.37 | N/A |
| BATAINDIA.BO | ₹700.40 | +1.77% | 89.5B | 52.54 | ₹13.25 | +2.73% |
| BATAINDIA.NS | ₹701.45 | +1.93% | 89.5B | 50.34 | ₹13.83 | +2.73% |
| RELAXO.BO | ₹304.40 | +3.36% | 74.3B | 44.38 | ₹6.73 | +1.00% |
| SAFARI.NS | ₹1,540.00 | +0.85% | 74.2B | 44.31 | ₹34.20 | +0.23% |
| SAFARI.BO | ₹1,537.75 | +0.63% | 74.2B | 44.27 | ₹34.20 | +0.23% |
| REDTAPE.NS | ₹137.10 | +2.26% | 73.6B | 34.77 | ₹3.83 | +0.56% |
Stock Comparison
RELAXO.NS vs METROBRAND.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, METROBRAND.NS has a market cap of 292.7B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while METROBRAND.NS trades at ₹1,065.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas METROBRAND.NS's P/E ratio is 71.27. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to METROBRAND.NS's ROE of +0.23%. Regarding short-term risk, RELAXO.NS is more volatile compared to METROBRAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check METROBRAND.NS's competition here
RELAXO.NS vs METROBRAND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, METROBRAND.BO has a market cap of 291.9B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while METROBRAND.BO trades at ₹1,072.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas METROBRAND.BO's P/E ratio is 71.12. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to METROBRAND.BO's ROE of +0.23%. Regarding short-term risk, RELAXO.NS is more volatile compared to METROBRAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check METROBRAND.BO's competition here
RELAXO.NS vs SAFARIND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SAFARIND.BO has a market cap of 91.1B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SAFARIND.BO trades at ₹1,915.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SAFARIND.BO's P/E ratio is 1394.97. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SAFARIND.BO's ROE of N/A. Regarding short-term risk, RELAXO.NS is less volatile compared to SAFARIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check SAFARIND.BO's competition here
RELAXO.NS vs BATAINDIA.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BATAINDIA.BO has a market cap of 89.5B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BATAINDIA.BO trades at ₹700.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BATAINDIA.BO's P/E ratio is 52.54. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BATAINDIA.BO's ROE of +0.12%. Regarding short-term risk, RELAXO.NS is more volatile compared to BATAINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check BATAINDIA.BO's competition here
RELAXO.NS vs BATAINDIA.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BATAINDIA.NS has a market cap of 89.5B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BATAINDIA.NS trades at ₹701.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BATAINDIA.NS's P/E ratio is 50.34. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BATAINDIA.NS's ROE of +0.12%. Regarding short-term risk, RELAXO.NS is more volatile compared to BATAINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check BATAINDIA.NS's competition here
RELAXO.NS vs RELAXO.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, RELAXO.BO has a market cap of 74.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while RELAXO.BO trades at ₹304.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas RELAXO.BO's P/E ratio is 44.38. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to RELAXO.BO's ROE of +0.08%. Regarding short-term risk, RELAXO.NS is more volatile compared to RELAXO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check RELAXO.BO's competition here
RELAXO.NS vs SAFARI.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SAFARI.NS has a market cap of 74.2B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SAFARI.NS trades at ₹1,540.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SAFARI.NS's P/E ratio is 44.31. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SAFARI.NS's ROE of +0.17%. Regarding short-term risk, RELAXO.NS is more volatile compared to SAFARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SAFARI.NS's competition here
RELAXO.NS vs SAFARI.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SAFARI.BO has a market cap of 74.2B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SAFARI.BO trades at ₹1,537.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SAFARI.BO's P/E ratio is 44.27. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SAFARI.BO's ROE of +0.17%. Regarding short-term risk, RELAXO.NS is more volatile compared to SAFARI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SAFARI.BO's competition here
RELAXO.NS vs REDTAPE.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, REDTAPE.NS has a market cap of 73.6B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while REDTAPE.NS trades at ₹137.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas REDTAPE.NS's P/E ratio is 34.77. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, RELAXO.NS is less volatile compared to REDTAPE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check REDTAPE.NS's competition here
RELAXO.NS vs REDTAPE.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, REDTAPE.BO has a market cap of 73.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while REDTAPE.BO trades at ₹137.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas REDTAPE.BO's P/E ratio is 34.52. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to REDTAPE.BO's ROE of +0.27%. Regarding short-term risk, RELAXO.NS is less volatile compared to REDTAPE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check REDTAPE.BO's competition here
RELAXO.NS vs CAMPUS.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CAMPUS.BO has a market cap of 72.4B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CAMPUS.BO trades at ₹251.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CAMPUS.BO's P/E ratio is 51.48. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CAMPUS.BO's ROE of +0.19%. Regarding short-term risk, RELAXO.NS is less volatile compared to CAMPUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check CAMPUS.BO's competition here
RELAXO.NS vs CAMPUS.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CAMPUS.NS has a market cap of 72.1B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CAMPUS.NS trades at ₹253.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CAMPUS.NS's P/E ratio is 51.09. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CAMPUS.NS's ROE of +0.19%. Regarding short-term risk, RELAXO.NS is less volatile compared to CAMPUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check CAMPUS.NS's competition here
RELAXO.NS vs VIPIND.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, VIPIND.NS has a market cap of 43.6B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while VIPIND.NS trades at ₹305.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas VIPIND.NS's P/E ratio is -12.89. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to VIPIND.NS's ROE of -0.68%. Regarding short-term risk, RELAXO.NS is more volatile compared to VIPIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check VIPIND.NS's competition here
RELAXO.NS vs VIPIND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, VIPIND.BO has a market cap of 43.6B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while VIPIND.BO trades at ₹303.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas VIPIND.BO's P/E ratio is -22.24. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to VIPIND.BO's ROE of -0.68%. Regarding short-term risk, RELAXO.NS is more volatile compared to VIPIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check VIPIND.BO's competition here
RELAXO.NS vs BIL.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BIL.BO has a market cap of 10B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BIL.BO trades at ₹743.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BIL.BO's P/E ratio is 25.92. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BIL.BO's ROE of +0.08%. Regarding short-term risk, RELAXO.NS is less volatile compared to BIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check BIL.BO's competition here
RELAXO.NS vs KARNIKA.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, KARNIKA.NS has a market cap of 9.9B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while KARNIKA.NS trades at ₹137.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas KARNIKA.NS's P/E ratio is 44.93. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to KARNIKA.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is less volatile compared to KARNIKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check KARNIKA.NS's competition here
RELAXO.NS vs BIL.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BIL.NS has a market cap of 9.8B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BIL.NS trades at ₹740.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BIL.NS's P/E ratio is 25.55. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BIL.NS's ROE of +0.08%. Regarding short-term risk, RELAXO.NS is less volatile compared to BIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check BIL.NS's competition here
RELAXO.NS vs BIZOTIC.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BIZOTIC.BO has a market cap of 5.7B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BIZOTIC.BO trades at ₹726.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BIZOTIC.BO's P/E ratio is 55.26. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BIZOTIC.BO's ROE of +0.18%. Regarding short-term risk, RELAXO.NS is more volatile compared to BIZOTIC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check BIZOTIC.BO's competition here
RELAXO.NS vs SREEL.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SREEL.BO has a market cap of 4.4B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SREEL.BO trades at ₹188.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SREEL.BO's P/E ratio is 18.26. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SREEL.BO's ROE of +0.05%. Regarding short-term risk, RELAXO.NS is less volatile compared to SREEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check SREEL.BO's competition here
RELAXO.NS vs SREEL.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SREEL.NS has a market cap of 4.4B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SREEL.NS trades at ₹190.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SREEL.NS's P/E ratio is 18.18. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SREEL.NS's ROE of +0.05%. Regarding short-term risk, RELAXO.NS is more volatile compared to SREEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SREEL.NS's competition here
RELAXO.NS vs LEHAR.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, LEHAR.BO has a market cap of 4.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while LEHAR.BO trades at ₹247.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas LEHAR.BO's P/E ratio is 19.88. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to LEHAR.BO's ROE of +0.17%. Regarding short-term risk, RELAXO.NS is more volatile compared to LEHAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check LEHAR.BO's competition here
RELAXO.NS vs MIRZAINT.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, MIRZAINT.NS has a market cap of 4.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while MIRZAINT.NS trades at ₹31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas MIRZAINT.NS's P/E ratio is 50.05. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to MIRZAINT.NS's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to MIRZAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check MIRZAINT.NS's competition here
RELAXO.NS vs MIRZAINT.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, MIRZAINT.BO has a market cap of 4.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while MIRZAINT.BO trades at ₹30.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas MIRZAINT.BO's P/E ratio is 49.97. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to MIRZAINT.BO's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to MIRZAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check MIRZAINT.BO's competition here
RELAXO.NS vs LIBERTSHOE.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, LIBERTSHOE.BO has a market cap of 4.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while LIBERTSHOE.BO trades at ₹251.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas LIBERTSHOE.BO's P/E ratio is 37.14. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to LIBERTSHOE.BO's ROE of +0.05%. Regarding short-term risk, RELAXO.NS is more volatile compared to LIBERTSHOE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check LIBERTSHOE.BO's competition here
RELAXO.NS vs LIBERTSHOE.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, LIBERTSHOE.NS has a market cap of 4.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while LIBERTSHOE.NS trades at ₹253.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas LIBERTSHOE.NS's P/E ratio is 37.05. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to LIBERTSHOE.NS's ROE of +0.05%. Regarding short-term risk, RELAXO.NS is less volatile compared to LIBERTSHOE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check LIBERTSHOE.NS's competition here
RELAXO.NS vs GRETEX.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, GRETEX.NS has a market cap of 4B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while GRETEX.NS trades at ₹246.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas GRETEX.NS's P/E ratio is 269.79. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to GRETEX.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is more volatile compared to GRETEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check GRETEX.NS's competition here
RELAXO.NS vs MANBRO.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, MANBRO.BO has a market cap of 3.9B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while MANBRO.BO trades at ₹68.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas MANBRO.BO's P/E ratio is 215.48. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to MANBRO.BO's ROE of +0.11%. Regarding short-term risk, RELAXO.NS is less volatile compared to MANBRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check MANBRO.BO's competition here
RELAXO.NS vs OMNITEX.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, OMNITEX.BO has a market cap of 3.1B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while OMNITEX.BO trades at ₹761.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas OMNITEX.BO's P/E ratio is 10571.43. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to OMNITEX.BO's ROE of +0.00%. Regarding short-term risk, RELAXO.NS is less volatile compared to OMNITEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check OMNITEX.BO's competition here
RELAXO.NS vs BCONCEPTS.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BCONCEPTS.BO has a market cap of 2.6B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BCONCEPTS.BO trades at ₹205.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BCONCEPTS.BO's P/E ratio is 50.61. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BCONCEPTS.BO's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is less volatile compared to BCONCEPTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check BCONCEPTS.BO's competition here
RELAXO.NS vs BCONCEPTS.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BCONCEPTS.NS has a market cap of 2.6B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BCONCEPTS.NS trades at ₹202.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BCONCEPTS.NS's P/E ratio is 50.42. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BCONCEPTS.NS's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is less volatile compared to BCONCEPTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check BCONCEPTS.NS's competition here
RELAXO.NS vs VIRAT.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, VIRAT.BO has a market cap of 2.5B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while VIRAT.BO trades at ₹494.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas VIRAT.BO's P/E ratio is 150.62. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to VIRAT.BO's ROE of +0.08%. Regarding short-term risk, RELAXO.NS is less volatile compared to VIRAT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check VIRAT.BO's competition here
RELAXO.NS vs CPS.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CPS.NS has a market cap of 2.3B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CPS.NS trades at ₹990.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CPS.NS's P/E ratio is 1251.90. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CPS.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is less volatile compared to CPS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check CPS.NS's competition here
RELAXO.NS vs ACTIVE.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, ACTIVE.BO has a market cap of 2.2B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while ACTIVE.BO trades at ₹130.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas ACTIVE.BO's P/E ratio is 21.73. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to ACTIVE.BO's ROE of +0.13%. Regarding short-term risk, RELAXO.NS is less volatile compared to ACTIVE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check ACTIVE.BO's competition here
RELAXO.NS vs VANDANA.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, VANDANA.BO has a market cap of 2B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while VANDANA.BO trades at ₹18.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas VANDANA.BO's P/E ratio is 1828.00. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to VANDANA.BO's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to VANDANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check VANDANA.BO's competition here
RELAXO.NS vs KHADIM.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, KHADIM.BO has a market cap of 1.9B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while KHADIM.BO trades at ₹104.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas KHADIM.BO's P/E ratio is 24.37. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to KHADIM.BO's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to KHADIM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check KHADIM.BO's competition here
RELAXO.NS vs KHADIM.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, KHADIM.NS has a market cap of 1.9B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while KHADIM.NS trades at ₹103.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas KHADIM.NS's P/E ratio is 24.29. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to KHADIM.NS's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to KHADIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check KHADIM.NS's competition here
RELAXO.NS vs SUPERHOUSE.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SUPERHOUSE.NS has a market cap of 1.7B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SUPERHOUSE.NS trades at ₹154.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SUPERHOUSE.NS's P/E ratio is 25.87. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SUPERHOUSE.NS's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to SUPERHOUSE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SUPERHOUSE.NS's competition here
RELAXO.NS vs SUPERHOUSE.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SUPERHOUSE.BO has a market cap of 1.7B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SUPERHOUSE.BO trades at ₹152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SUPERHOUSE.BO's P/E ratio is 25.75. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SUPERHOUSE.BO's ROE of +0.01%. Regarding short-term risk, RELAXO.NS is more volatile compared to SUPERHOUSE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SUPERHOUSE.BO's competition here
RELAXO.NS vs SCOOBEEDAY.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SCOOBEEDAY.BO has a market cap of 1B. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SCOOBEEDAY.BO trades at ₹73.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SCOOBEEDAY.BO's P/E ratio is N/A. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SCOOBEEDAY.BO's ROE of -0.60%. Regarding short-term risk, RELAXO.NS is less volatile compared to SCOOBEEDAY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check SCOOBEEDAY.BO's competition here
RELAXO.NS vs CRAVATEX.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CRAVATEX.BO has a market cap of 876.9M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CRAVATEX.BO trades at ₹339.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CRAVATEX.BO's P/E ratio is 13.22. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CRAVATEX.BO's ROE of +0.06%. Regarding short-term risk, RELAXO.NS is more volatile compared to CRAVATEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check CRAVATEX.BO's competition here
RELAXO.NS vs ACKNIT.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, ACKNIT.BO has a market cap of 835.4M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while ACKNIT.BO trades at ₹274.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas ACKNIT.BO's P/E ratio is 10.81. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to ACKNIT.BO's ROE of +0.09%. Regarding short-term risk, RELAXO.NS is more volatile compared to ACKNIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check ACKNIT.BO's competition here
RELAXO.NS vs CEENIK.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CEENIK.BO has a market cap of 819.7M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CEENIK.BO trades at ₹205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CEENIK.BO's P/E ratio is -10.06. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CEENIK.BO's ROE of -0.49%. Regarding short-term risk, RELAXO.NS is less volatile compared to CEENIK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check CEENIK.BO's competition here
RELAXO.NS vs BANARBEADS.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BANARBEADS.NS has a market cap of 757M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BANARBEADS.NS trades at ₹112.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BANARBEADS.NS's P/E ratio is 40.17. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BANARBEADS.NS's ROE of +0.03%. Regarding short-term risk, RELAXO.NS is less volatile compared to BANARBEADS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check BANARBEADS.NS's competition here
RELAXO.NS vs BANARBEADS.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BANARBEADS.BO has a market cap of 751.6M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BANARBEADS.BO trades at ₹112.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BANARBEADS.BO's P/E ratio is 39.88. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BANARBEADS.BO's ROE of +0.03%. Regarding short-term risk, RELAXO.NS is more volatile compared to BANARBEADS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check BANARBEADS.BO's competition here
RELAXO.NS vs GARMNTMNTR.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, GARMNTMNTR.BO has a market cap of 740.3M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while GARMNTMNTR.BO trades at ₹1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas GARMNTMNTR.BO's P/E ratio is 4.03. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to GARMNTMNTR.BO's ROE of +0.23%. Regarding short-term risk, RELAXO.NS is less volatile compared to GARMNTMNTR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check GARMNTMNTR.BO's competition here
RELAXO.NS vs ELAND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, ELAND.BO has a market cap of 681M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while ELAND.BO trades at ₹14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas ELAND.BO's P/E ratio is -2.27. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to ELAND.BO's ROE of +0.06%. Regarding short-term risk, RELAXO.NS is less volatile compared to ELAND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check ELAND.BO's competition here
RELAXO.NS vs JAIPURKURT.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, JAIPURKURT.NS has a market cap of 571.4M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while JAIPURKURT.NS trades at ₹32.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas JAIPURKURT.NS's P/E ratio is 13.73. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to JAIPURKURT.NS's ROE of +0.03%. Regarding short-term risk, RELAXO.NS is less volatile compared to JAIPURKURT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check JAIPURKURT.NS's competition here
RELAXO.NS vs AKI.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, AKI.BO has a market cap of 505.7M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while AKI.BO trades at ₹4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas AKI.BO's P/E ratio is 12.89. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to AKI.BO's ROE of +0.04%. Regarding short-term risk, RELAXO.NS is less volatile compared to AKI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check AKI.BO's competition here
RELAXO.NS vs AKI.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, AKI.NS has a market cap of 503.6M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while AKI.NS trades at ₹4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas AKI.NS's P/E ratio is 12.84. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to AKI.NS's ROE of +0.04%. Regarding short-term risk, RELAXO.NS is less volatile compared to AKI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check AKI.NS's competition here
RELAXO.NS vs SUNILTX.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SUNILTX.BO has a market cap of 324.1M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SUNILTX.BO trades at ₹77.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SUNILTX.BO's P/E ratio is 6.33. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SUNILTX.BO's ROE of +0.10%. Regarding short-term risk, RELAXO.NS is more volatile compared to SUNILTX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SUNILTX.BO's competition here
RELAXO.NS vs SPENTA.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SPENTA.BO has a market cap of 281.9M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SPENTA.BO trades at ₹102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SPENTA.BO's P/E ratio is -268.39. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SPENTA.BO's ROE of -0.00%. Regarding short-term risk, RELAXO.NS is more volatile compared to SPENTA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SPENTA.BO's competition here
RELAXO.NS vs SIGNORIA.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SIGNORIA.NS has a market cap of 271.2M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SIGNORIA.NS trades at ₹57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SIGNORIA.NS's P/E ratio is 8.99. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SIGNORIA.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is more volatile compared to SIGNORIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SIGNORIA.NS's competition here
RELAXO.NS vs SCARNOSE.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SCARNOSE.BO has a market cap of 239.4M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SCARNOSE.BO trades at ₹76.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SCARNOSE.BO's P/E ratio is 104.11. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SCARNOSE.BO's ROE of +0.02%. Regarding short-term risk, RELAXO.NS is more volatile compared to SCARNOSE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SCARNOSE.BO's competition here
RELAXO.NS vs VIVAA.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, VIVAA.BO has a market cap of 173.3M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while VIVAA.BO trades at ₹44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas VIVAA.BO's P/E ratio is 15.44. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to VIVAA.BO's ROE of +0.04%. Regarding short-term risk, RELAXO.NS is more volatile compared to VIVAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check VIVAA.BO's competition here
RELAXO.NS vs CITYMAN.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CITYMAN.BO has a market cap of 170.8M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CITYMAN.BO trades at ₹15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CITYMAN.BO's P/E ratio is -52.14. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CITYMAN.BO's ROE of +0.05%. Regarding short-term risk, RELAXO.NS is less volatile compared to CITYMAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check CITYMAN.BO's competition here
RELAXO.NS vs JIWANRAM.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, JIWANRAM.NS has a market cap of 138.6M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while JIWANRAM.NS trades at ₹5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas JIWANRAM.NS's P/E ratio is 6.09. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to JIWANRAM.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is more volatile compared to JIWANRAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check JIWANRAM.NS's competition here
RELAXO.NS vs MISHDESIGN.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, MISHDESIGN.BO has a market cap of 121.4M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while MISHDESIGN.BO trades at ₹38.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas MISHDESIGN.BO's P/E ratio is 17.18. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to MISHDESIGN.BO's ROE of +0.03%. Regarding short-term risk, RELAXO.NS is less volatile compared to MISHDESIGN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check MISHDESIGN.BO's competition here
RELAXO.NS vs NEWLIGHT.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, NEWLIGHT.BO has a market cap of 120.9M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while NEWLIGHT.BO trades at ₹1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas NEWLIGHT.BO's P/E ratio is 19.71. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to NEWLIGHT.BO's ROE of +0.04%. Regarding short-term risk, RELAXO.NS is less volatile compared to NEWLIGHT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check NEWLIGHT.BO's competition here
RELAXO.NS vs WELTI.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, WELTI.BO has a market cap of 115.9M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while WELTI.BO trades at ₹26.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas WELTI.BO's P/E ratio is -43.48. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to WELTI.BO's ROE of +0.02%. Regarding short-term risk, RELAXO.NS is less volatile compared to WELTI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check WELTI.BO's competition here
RELAXO.NS vs NBFOOT.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, NBFOOT.BO has a market cap of 115M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while NBFOOT.BO trades at ₹8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas NBFOOT.BO's P/E ratio is -50.12. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to NBFOOT.BO's ROE of +141.74%. Regarding short-term risk, RELAXO.NS is less volatile compared to NBFOOT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check NBFOOT.BO's competition here
RELAXO.NS vs BILLWIN.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, BILLWIN.BO has a market cap of 107.8M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while BILLWIN.BO trades at ₹25.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas BILLWIN.BO's P/E ratio is 18.70. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to BILLWIN.BO's ROE of +0.02%. Regarding short-term risk, RELAXO.NS is more volatile compared to BILLWIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check BILLWIN.BO's competition here
RELAXO.NS vs CBAZAAR.NS Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, CBAZAAR.NS has a market cap of 91.2M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while CBAZAAR.NS trades at ₹4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas CBAZAAR.NS's P/E ratio is -2.19. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to CBAZAAR.NS's ROE of N/A. Regarding short-term risk, RELAXO.NS is more volatile compared to CBAZAAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check CBAZAAR.NS's competition here
RELAXO.NS vs KARANWO.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, KARANWO.BO has a market cap of 74.7M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while KARANWO.BO trades at ₹9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas KARANWO.BO's P/E ratio is -10.19. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to KARANWO.BO's ROE of +0.29%. Regarding short-term risk, RELAXO.NS is more volatile compared to KARANWO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check KARANWO.BO's competition here
RELAXO.NS vs EUROLED.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, EUROLED.BO has a market cap of 72.3M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while EUROLED.BO trades at ₹16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas EUROLED.BO's P/E ratio is 27.39. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to EUROLED.BO's ROE of +0.02%. Regarding short-term risk, RELAXO.NS is less volatile compared to EUROLED.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check EUROLED.BO's competition here
RELAXO.NS vs SRIND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SRIND.BO has a market cap of 61.4M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SRIND.BO trades at ₹3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SRIND.BO's P/E ratio is -2.74. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SRIND.BO's ROE of -0.07%. Regarding short-term risk, RELAXO.NS is less volatile compared to SRIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check SRIND.BO's competition here
RELAXO.NS vs SIDDHEGA.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, SIDDHEGA.BO has a market cap of 55.6M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while SIDDHEGA.BO trades at ₹17.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas SIDDHEGA.BO's P/E ratio is 420.00. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to SIDDHEGA.BO's ROE of +0.00%. Regarding short-term risk, RELAXO.NS is more volatile compared to SIDDHEGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check SIDDHEGA.BO's competition here
RELAXO.NS vs RICHAIND.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, RICHAIND.BO has a market cap of 38.7M. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while RICHAIND.BO trades at ₹1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas RICHAIND.BO's P/E ratio is -0.17. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to RICHAIND.BO's ROE of +0.08%. Regarding short-term risk, RELAXO.NS is less volatile compared to RICHAIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELAXO.NS.Check RICHAIND.BO's competition here
RELAXO.NS vs AKM.BO Comparison May 2026
RELAXO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELAXO.NS stands at 74.4B. In comparison, AKM.BO has a market cap of 0. Regarding current trading prices, RELAXO.NS is priced at ₹303.00, while AKM.BO trades at ₹122.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELAXO.NS currently has a P/E ratio of 44.32, whereas AKM.BO's P/E ratio is N/A. In terms of profitability, RELAXO.NS's ROE is +0.08%, compared to AKM.BO's ROE of N/A. Regarding short-term risk, RELAXO.NS is more volatile compared to AKM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELAXO.NS.Check AKM.BO's competition here